The second and third extracellular domains of FcγRI (CD64) confer the unique high affinity binding of IgG2a

Molecular Immunology

Volumn 35, Issue 14-15, 1998, Pages 989-996

  Hulett, Mark D ^a   Hogarth, P Mark ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

CD64; Fc receptor; Fc RI; Ig superfamily; IgG

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G2A;

ARTICLE; BINDING SITE; MOLECULAR INTERACTION; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTOR AFFINITY;

ANIMALS; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; COS CELLS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS;

EID: 0031674586     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00069-8     Document Type: Article

References (45)

1. Allen J.M., Seed B. Science. 243:1989;378-381.
2. Anderson C.L., Guyre P.M., Whitin J.C., Ryan D.H., Looney R.J., Fanger M.W. Antibody characterization and induction of superoxide production in a monocyte cell. J. Biol. Chem. 261:1986;12856-12864.
3. Anderson C.L., Shen L., Eicher D.M., Wewers M.D., Gill J.K. J. Exp. Med. 171:1990;1245-1333.
4. Debets J.M.H., van de Winkel J.G.J., Ceuppens J.L., Dieteren I.E.M., Buurman W.A. J. Immunol. 144:1990;1304-1310.
5. Fanger, N.A., Yeaman, G.R., Guyre, P.M., 1996. Regulation of FcγR expression and function by cytokines and hormones. In: van de Winkel, J.G.J., Capel, P.J.A. (Eds). Human IgG Fc Receptors, R.G. Landes Company, Austin, p. 123.
6. Gavin A.L., Barnes N., Dijstelbloem H.M., Hogarth P.M. J. Immunol. 160:1998;20-23.
7. Gosselin E.J., Wardwell K., Gosselin D.R., Alter N., Fisher J.L., Guyre P.M. J. Immunol. 149:1992;3477-3481.
8. Graziano R.F., Fanger M.W. J. Immunol. 139:1987;3536-3541.
9. Guyre P.M., Morganelli P.M., Miller R. J. Clin. Invest. 72:1983;393-397.
10. Heijnen I.A.F.M., van Vugt M.J., Fanger N.a., Graziano R.f., de Wit T.p., Hofhuis F.m., Guyre P.m., Capel P.j.a., van de Winkel J.g.g. J. Clin. Invest. 97:1996;331-338.
11. Hibbs M.L., Tolvanen M., Carpen O. J. Immunol. 152:1994;4466-4474.
12. Hogarth P.M., Edwards J., McKenzie I.F.C., Liew F.Y. Immunology. 46:1982;135-144.
13. Hogarth P.M., Hibbs M.L., Bonadonna L., Scott B.M., Witort E., Pietersz G.A., McKenzie I.F.C. Molecular cloning and specificity. Immunogenetics. 26:1987;161-168.
14. Horton R.M., Hunt H.D., Ho S.N., Pullin J.K., Pease L.R. Gene. 77:1989;61-68.
15. Hulett M.D., Hogarth P.M. Adv. Immunol. 57:1994;1-127.
16. Hulett M.D., Osman N., McKenzie I.F.C., Hogarth P.M. J. Immunol. 147:1991;1863-1868.
17. Hulett M.D., McKenzie I.F.C., Hogarth P.M. J. Immunol. 23:1993;640-645.
18. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F.C., Hogarth P.M. J. Biol. Chem. 269:1994;15287-15293.
19. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F.C., Hogarth P.M. J. Biol. Chem. 270:1995;21188-21194.
20. Kraft R., Tardiff J., Krauter K.S., Leinward L.A. Biotechniques. 6:1988;544-547.
21. Krutmann J., Kirnbauer R., Kock A., Schwartz T., Schopf E., May L.T., Seghal P.B., Luger T.A. J. Immunol. 145:1990;1337-1342.
22. Lewis et al., 1986.
23. Lopez A.F., Strath M., Sanderson C.J. Immunology. 48:1983;503-509.
24. Mallimaci M.A., Chizzonite R., Griffen M., Nettleton M., Hakimi J., Tsien W.-H., Kochan J.P. J. Biol. Chem. 268:1993;22079-22083.
25. McDonnell J.M., Beavil A.J., Mackay G.A., Jameson B.A., Korngold R., Gould H.J., Sutton B.J. Nature Struct. Biol. 3:1996;419-426.
26. Mellman I., Koch T., Healey G., Hunziker W., Lewis V., Plutner H., Miettinen H., Vaux D., Moore K., Stuart S. J. Cell. Sci. Suppl. 9:1988;45-65.
27. Osman N., Kozak C.A., McKenzie I.F.C., Hogarth P.M. J. Immunol. 148:1992;1570-1575.
28. Pan L., Mendel D.B., Zurlo J., Guyre P.M. J. Immunol. 145:1990;267-275.
29. Perussia B., Starr S., Abraham S., Fanning V., Trinchieri G. J. Immunol. 130:1983;2133-2141.
30. Porges et al., 1992.
31. Ravetch J.V., Kinet J.P. Annu. Rev. Immunol. 9:1991;457-492.
32. Repp R., Valerius T., Sendler A., Gramatzki M., Iro H., Kalden J.R., Platzer E. Blood. 78:1991;885-889.
33. Robinson M.W. J. Biol. Chem. 268:1993;12736-12743.
34. Sanger F., Nicklen S., Nicklen A.R., Coulson O.M. Proc. Natl. Acad. Sci. U.S.A. 74:1977;5463-5467.
35. Sears D.W., Osman N., Tate B., McKenzie I.F.C., Hogarth P.M. J. Immunol. 144:1990;317-378.
36. Seed B., Aruffo A. Proc. Natl. Acad. Sci. U.S.A. 84:1987;3365-3369.
37. Shen L., Guyre P.M., Anderson C.L., Fanger M.W. J. Immunol. 137:1986;3378-3382.
38. Simmons D., Seed B. Nature. 333:1988;568-570.
39. Stengelin et al., 1988.
40. Tamm A., Kister A., Nolte K.U., Gessner J.E., Schmidt R.E. J. Biol. Chem. 271:1996;3659-3666.
41. Unkeless J.C., Scigliano E., Freedman V.H. Annu. Rev. Immunol. 6:1988;251-281.
42. Winkel J.G.J., Anderson C.L. J. Leuk. Biol. 49:1991;511-524.
43. Winkel J.G.J., Capel P.J.A. Immunol. Today. 14:1993;215-221.
44. Winkel, J.G.J., Capel P.J.A., 1996. Human IgG Fc receptor yellow pages. In: van de Winkel, J.G.J., Capel, P.J.A. (Eds). Human IgG Fc Receptors, R.G. Landes Company, Austin, pp. 227.
45. Doren K., Hanahan D., Gluzman Y. J. Virol. 50:1984;606.